Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

TRAF1 anticorps (AA 73-219)

TRAF1 Reactivité: Humain IHC, StM Hôte: Souris Monoclonal TRAF1-2770 unconjugated
N° du produit ABIN6940805
  • Antigène Voir toutes TRAF1 Anticorps
    TRAF1 (TNF Receptor-Associated Factor 1 (TRAF1))
    Épitope
    • 15
    • 8
    • 7
    • 6
    • 6
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    AA 73-219
    Reactivité
    • 50
    • 31
    • 18
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    Humain
    Hôte
    • 43
    • 9
    • 1
    Souris
    Clonalité
    • 46
    • 7
    Monoclonal
    Conjugué
    • 29
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp TRAF1 est non-conjugé
    Application
    • 35
    • 23
    • 13
    • 13
    • 8
    • 5
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    Immunohistochemistry (IHC), Staining Methods (StM)
    Specificité
    This MAb recognizes a protein of 52 kDa, which is identified as TNFR1 (TNFR-associated factor 1). CD30-positive lymphoproliferations of the skin comprise 30 % of all primary cutaneous T-cell lymphomas (CTCLs). Besides borderline cases this group includes lymphomatoid papulosis (LyP) and primary cutaneous anaplastic large T-cell lymphoma (cALCL). Although the two entities overlap clinically, histopathologically, immunopathologically and genetically, they differ considerably in their prognosis. In particular, common feature of both cases is histologically the presence of atypical lymphoid CD30-positive T blasts and genetically a clonal T-cell-receptor rearrangement. However, both cases differ considerably in their clinical course: Lesions of LyP regress spontaneously, whereas those of cALCL persist and may progress and spread. Moreover, LyP patients do not benefit from an aggressive radio- and/or chemotherapeutic approach, in contrast to patients with cALCL. Besides, LyP and cALCL differ strongly in the expression of TRAF1 (tumor necrosis factor receptor (TNFR)-associated factor 1), a component of TNFR signaling: Whereas tumor cells of most LyP cases (ca. 84 %) show a strong TRAF1 expression, tumor cells of cALCL reveal TRAF1 expression in only a few cases (ca. 7 %). Antibody to TRAF1 is highly useful for the differentiation of LyP and cALCL in patients with cutaneous CD30-positive lymphoproliferations.
    Purification
    Purified by Protein A/G
    Immunogène
    Recombinant fragment of human TRAF1 protein (around aa 73-219) (exact sequence is proprietary)
    Clone
    TRAF1-2770
    Isotype
    IgG1 kappa
    Top Product
    Discover our top product TRAF1 Anticorps primaire
  • Indications d'application

    Positive Control: HeLa or 293T cells. Hodgkin s Lymphoma (IHC).

    Known Application: Immunohistochemistry (Formalin-fixed) (1-2 μg/mL for 30 minutes at RT) ,(Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes),Optimal dilution for a specific application should be determined.

    Restrictions
    For Research Use only
  • Concentration
    200 μg/mL
    Buffer
    10 mM PBS with 0.05 % BSA & 0.05 % azide.
    Agent conservateur
    Sodium azide
    Précaution d'utilisation
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    4 °C,-80 °C
    Stockage commentaire
    Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months. Non-hazardous. No MSDS required.
    Date de péremption
    24 months
  • Antigène
    TRAF1 (TNF Receptor-Associated Factor 1 (TRAF1))
    Autre désignation
    TRAF1 (TRAF1 Produits)
    Synonymes
    anticorps CG3048, anticorps DTRAF, anticorps DTRAF1, anticorps Dmel\\CG3048, anticorps TRAF, anticorps TRAF1, anticorps Traf1, anticorps dTRAF, anticorps dTRAF1, anticorps dTraf1, anticorps dtraf1, anticorps traf1, anticorps traf4, anticorps DKFZp469G032, anticorps EBI6, anticorps MGC:10353, anticorps 4732496E14Rik, anticorps TNF receptor associated factor 1, anticorps TNF-receptor-associated factor 4, anticorps TNF receptor-associated factor 1, anticorps TRAF1, anticorps Traf4, anticorps Traf1, anticorps traf1
    Poids moléculaire
    52kDa
    ID gène
    7185
    UniProt
    Q13077
    Pathways
    Signalisation NF-kappaB, Apoptose, Cell-Cell Junction Organization, Asymmetric Protein Localization
Vous êtes ici:
Support technique